Tyra Biosciences, Inc., a biotechnology company in the clinical development stage, revealed that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for TYRA-300, enabling the company to move...
Lyell Immunopharma, Inc, located in South San Francisco, revealed that it has finalized a deal to purchase ImmPACT Bio USA Inc, a clinical-stage biotech company, as part of its efforts to develop advanced CAR T-cell therapies for cancer...
Abbott introduced a unique clinical trial aimed at enhancing results in patients with worsening heart failure who may benefit from advanced treatment choices. The TEAM-HF study aims to include a maximum of 850 participants from 75 locations...
Dr. Poovamma CU - Senior Consultant & Director - Breast Oncology, Cytecare Hospitals in a recent interaction with India Pharma Outlook shares her views on how innovations such as AI-driven imaging
Find Therapeutics, a biopharmaceutical company in the clinical stage, has started administering doses of FTX-101 in its phase 1 clinical trial involving healthy participants. FTX-101 is a novel therapeutic peptide that controls the Plexin...
Ionis Pharmaceuticals, Inc. revealed that the Committee for Medicinal Products for Human Use (CHMP) in the European Union (EU) has recommended the approval of Ionis' and AstraZeneca's Wainzua (eplontersen) for treating hereditary transthyretin...
Oculis Holding AG (Oculis) has sped up the enrollment of patients for the phase 3 DIAMOND clinical trials of OCS-01 eye drops in DME and expanded the DIAMOND programme committees with leading retina specialists worldwide. Significant advancement...
National Institutes of Health (NIH) showed that an mpox vaccine administered to teenagers was safe and produced the same level of antibody response as in adults. Young people are one of the demographics impacted by mpox in the ongoing Clade I mpox...
Cullinan Therapeutics, Inc., a biopharmaceutical company specializing in developing targeted therapies, confirmed FDA approval for their Investigational New Drug Application for CLN-978. This enables the global phase 1 clinical trial in the US for...
Annovis Bio Inc, based in Malvern, a company in the advanced stages of clinical drug development, revealed on October 10, 2024, the positive results of their meeting with the US Food and Drug Administration regarding transformative treatments for...
, CDSCO.jpg)
